期刊
FUTURE ONCOLOGY
卷 10, 期 16, 页码 2629-2641出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon.14.197
关键词
autophagy; EGFR; JAK-STAT; oncolytic virus; pancreatic ductal adenocarcinoma; sonic hedgehog; stroma; tumor microenvironment
类别
资金
- Celgene
- Bayer phamaceuticals
Pancreatic ductal adenocarcinoma is a lethal disease due to late diagnosis, early metastasis and the lack of effective therapies. In patients with metastatic disease, 1-year survival ranges from 17 to 23% and 5-year survival is less than 5%. This necessitates an urgent need for developing more effective therapies. Targeting the neoplastic cells has been largely ineffective due to the dense stroma, which is a physical barrier for effective drug delivery and also a source for different factors that promote tumor progression and immunosuppression. In this review, we focus on understanding the complex biology of this tumor as it relates to the evaluation of previously failed molecularly targeted trials and review potential new therapies that are emerging in the treatment of metastatic pancreatic ductal adenocarcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据